Effect of phosducin on opioid receptor function

Journal of Pharmacology and Experimental Therapeutics

Volumn 289, Issue 1, 1999, Pages 599-606

  Schulz, Rüdiger ^a,c   Wehmeyer, Andrea ^a   Schulz, Karin ^a   Murphy, John ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^c Institute of Pharmacology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; ETORPHINE; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATASE; MU OPIATE RECEPTOR; PHOSDUCIN; PHOSPHOPROTEIN;

ANIMAL CELL; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG RECEPTOR BINDING; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; RECEPTOR INTRINSIC ACTIVITY;

CYCLIC AMP; DNA; ENKEPHALIN, D-PENICILLAMINE (2,5)-; ENKEPHALINS; EYE PROTEINS; FLOW CYTOMETRY; GLIOMA; GREEN FLUORESCENT PROTEINS; GTP PHOSPHOHYDROLASES; GTP-BINDING PROTEIN REGULATORS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; HYBRID CELLS; LUMINESCENT PROTEINS; MICROSCOPY, CONFOCAL; NERVE TISSUE PROTEINS; NEUROBLASTOMA; PHOSPHOPROTEINS; RADIOLIGAND ASSAY; RECEPTORS, OPIOID; RECOMBINANT FUSION PROTEINS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0032921952     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Ammer H and Schulz R (1993) Coupling of prostaglandin E1 receptors to the stimulatory GTP-binding protein Gs is enhanced in neuroblastoma × glioma (NG 108-15) hybrid cells chronically exposed to an opioid. Mol Pharmacol 43:556-563.
2. Ammer H and Schulz R (1997) Enhanced stimulatory adenylyl cyclase signaling during opioid dependence is associated with a reduction in palmitoylated Gs alpha. Mol Pharmacol. 52:993-999.
3. Bauer HB, Müller S, Puzicha M, Pippig S, Obermaier B, Helmreich EJM and Lohse M (1992) Phosducin is a protein kinase A-regulated G-protein regulator. Nature 358:73-76.
4. Bauer PH and Lohse MJ (1998) Effects of phosducin on the GTPase cycle of Go. Naunyn Schmiedebergs Arch Pharmacol 367:371-377.
5. Berman DM and Gilman AG (1998) Mammalian RGS proteins: Barbarians at the gate. J Biol Chem 273:1269-1272.
6. Blüml K, Schnepp W, Schröder S, Beyermann M, Macias M, Oschkinat H and Lohse MJ (1997) A small region in phosducin inhibits G-protein beta gamma-subunit function. EMBO J 16:4908-4915.
7. Breivogel CS, Selley DE and Childers SR (1997) Acute and chronic effects of opioids on δ and μ receptor activation of G proteins in NG 108-15 and SK-N-SH cell membranes. J Neurochem 68:1462-1472.
8. Chalfie M, Tu Y, Euskirchen G, Ward WW and Prasher DC (1994) Green fluorescent protein as a marker for gene expression. Science 263:802-805.
9. Chen Y, Mestek A, Liu J, Hurley JA and Yu L (1993) Molecular cloning and functional expression of a mu-opioid receptor from rat brain. Mol Pharmacol 44:8-12.
10. Clapham DE and Neer EJ ( 1997) G protein beta gamma subunits. Annu Rev Pharmacol Toxicol 37:167-203.
11. Cormack BP, Valdivia R and Falko S (1996) FACS-optimized mutants of the green fluorescent protein (GFP). Gene 17:33-38.
12. Cox BM (1993) Opioid receptor-G protein interactions: Acute and chronic effects of opioids, in Opioids I (Herz A ed) pp 145-180, Springer-Verlag, Berlin, Heidelberg.
13. Danner S and Lohse MJ (1996) Phosducin is an ubiquitous G-protein regulator. Proc Natl Acad Sci USA 93:10145-10150.
14. Fejes-Toth G, Pearce D, Naray-Fejes-Toth A (1998) Subcellular localization of mineralocorticoid receptors in living cells: Effects of receptor agonists and antagonists. Proc Natl Acad Sc USA 6:2973-2978.
15. Ferguson SSG and Caron MG (1998) G protein-coupled receptor adaptation mechanisms. Cell Dev Biol 9:119-127.
16. Ferguson SSG, Downey III WE, Colapietro A-M, Barak LS, Ménard L, Caron MG (1996) Role of beta-arrestin in mediating agonist-promoted G protein-coupled receptor internalization. Science 271:363-366.
17. Ford CE, Skiba NP, Bae H, Daaka Y, Reuveny E, Shekter LR, Rosal R, Weng G, Yang C-S, Iyengar R, Miller RJ, Jan LY, Lefkowitz RJ and Hamm HE (1998) Molecular basis for interactions of G protein βγ subunits with effectors. Science 280:1271-1277.
18. Gaudet R, Bohm A and Sigler PB (1996) Crystal structure at 2.4 angstrom resolution of the complex of transducin beta gamma and its regulator, phosducin. Cell 87:577-588.
19. Hawes BE, Touhara K, Kurose H, Lefkowitz RJ and Inglese J (1994) Determination of the G beta gamma-binding domain of phosducin: A regulatable modulator of G beta gamma signaling. J Biol Chem 269:29825-29830.
20. Keith DE, Anton B, Murray SR, Zaki PA, Chu PC, Lissin DV, Monteilet-Agius G, Stewart PL, Evans CJ and von Zastrow M (1998) μ-Opioid receptor internalization: Opiate drugs have differential effects on a conserved endocytic mechanism in vitro and in the mammalian brain. Mol Pharmacol 53:377-384.
21. Keith DE, Murray SR, Zaki PA, Chu PC, Lissin DV, Kang L, Evans CJ and von Zastrow M (1996) Morphine activates opioid receptors without causing their rapid internalization. J Biol Chem 271:19021-19024.
22. Lee RH, Lieberman BS and Lolley RN (1987) A novel complex from bovine visual cells of a 33,000-dalton phosphoprotein with beta-and gamma-transducin: Purification and subunit structure. Biochemistry 26: 3983-3990.
23. Lee RH, Ting TD, Lieberman BS, Tobias DE, Lolley RN and Ho YK (1992) Regulation of retinal cGMP cascade by phosducin in bovine rod photoreceptor cells: Interaction of phosducin and transducin. J Biol Chem 267:25104-25112.
24. Lin HC, Duncan JA, Kozasa T and Gilman A G (1998) Sequestration of the G protein βγ subunit complex inhibits receptor-mediated endocytosis. Proc Natl Acad Sci USA 95:5057-5060.
25. Lorenzen A, Fuss M and Schwabe U (1993) Measurement of guanine nucleotide-binding protein activation by A1 adenosine receptor agonists in bovine brain membranes: Stimulation of guanosine-5′-O-(3-[35S]thio)triphosphate binding. Mol Pharmacol 44:915-926.
26. Lowry OH, Rosenbrough NJ, Farr AL and Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275.
27. McKenzie FR and Milligan G (1990) δ-opioid-receptor-mediated inhibition of adenylate cyclase activity is transduced specifically by the guanine-nucleotide-binding protein Gi2. Biochem J 267:371-378.
28. Myburgh, DB, Millar RP and Hapgood JP ( 1998) Alanine-261 in intracellular loop III of the gonadotropin-releasing hormone receptor is crucial for G-protein coupling and receptor internalization. Biochem J 331:893-896.
29. Odagaki Y and Fuxe K (1997) Agonist-induced high-affinity GTP hydrolysis as an index of receptor-mediated G protein activation in mammalian brain membranes. Meth Mol Biol 83:133-141.
30. Pitcher JA, Touhara K, Payne ES and Lefkowitz RJ (1995) Pleckstrin homology domain-mediated membrane association and activation of the β-adrenergic receptor kinase requires coordinate interaction with the Gβγ subunit and lipid. J Biol Chem 270:11707-11710.
31. Prasher D, Eckenrode VK, Ward WW, Prendergast FG and Cormier MJ (1992) Primary structure of the aequorea victoria green fluorescent protein. Gene 111: 229-233.
32. Quock R., Hosohata Y, Knapp RJ, Burkey TH, Hosohata K, Zhang X, Rice KC, Nagase H, Hruby VJ, Porreca F, Roeske WR and Yamamura HI (1997) Relative efficacies of delta-opioid receptor agonists at the cloned human delta-opioid receptor. Eur J Pharmacol 326:101-104 .
33. Sambrook J, Fritsch EF and Maniatis T (1989) Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press. Cold Spring Harbor, NY.
34. Schulz K, Müller S, Belke-Louis G and Schulz R (1998a) Rat beta-adrenergic receptor kinases 1 and 2 in mouse neuroblastoma X rat glioma NG 108-15 hybrid cells. Biochem Pharmacol 55:65-70.
35. Schulz R, Schulz K, Wehmeyer A and Murphy J (1998b) Translocation of phosducin in living neuroblastoma × glioma hybrid cells (NG 108-15) monitored by red-shifted green fluorescent protein. Brain Res 790:347-356.
36. 35S]GTPγS binding in mMOR-CHO cells and rat thalamus. J Pharmacol Exp Ther 285:496-505.
37. Sloan-Lancaster LJ, Zhang WG, Presley J, Williams BL, Abraham RT, Lippincott Schwartz J and Samelson LE (1997) Regulation of ZAP-70 intracellular localization: Visualization with the green fluorescent protein J Exp Med 186:1713-1725.
38. Sternini C, Spann M, Anton B, Keith DE Jr, Bunnett NW, von Zastrow M, Evans C., Brecha NC (1996) Agonist-selective endocytosis of mu opioid receptor by neurons in vivo. Proc Nat Acad Sci USA 93:9241-9246.
39. Tarasova NI, Stauber RH, Choi JK, Hudson EA, Czerwinski G, Miller JL, Pavlakis GN, Michejda CJ and Wank SA (1997) Visualization of G protein-coupled receptor trafficking with the aid of the green fluorescent protein: Endocytosis and recycling of cholecystokinin receptor type A. J Biol Chem 23:14817-14824.
40. Thomas DR, Faruq SA, Balcarek JM and Brown AM (1995) Pharmacological characterization of [35S]-GTPγS binding to Chinese hamster ovary cell membranes stably expressing cloned human 5-HT1D receptor subtypes. J Recept Signal Transduct Res 15:199-211.
41. Vachon L, Costa T and Herz A (1987) Opioid receptor desensitization in NG 108-15 cells: Differential effects of a full and a partial agonist on the opioid-dependent GTPase. Biochem Pharmacol 36:2889-2897.
42. Wehmeyer A and Schulz R (1998) Phosducin expression in NG 108-15 hybrid cells enhances prostaglandin E1 stimulated adenylate cyclase activity. Life Sci 62:PL 127-134.
43. Wong GT, Gavin BJ and McMahon AP (1994) Differential transformation of mammary epithelial cells by Wnt genes. Mol Cell Biol 14:6278-6286.